Barrenjoey tips this ASX financial stock to rise 73%

A new deal has impressed the analysts.

The analysts at Barrenjoey are tipping significant upside for Navigator Global Investments Ltd (ASX: NGI) shares following the company's sale of its stake in Invictus Capital.

Woman looking at her computer and pondering something.

Image source: Getty Images

Strong return on investment

Earlier this week, Navigator said New York Life Investment Management would acquire a 60% stake in Invictus Capital Partners from Navigator and other shareholders, with the remaining interest to be purchased in 2031.

Navigator said the deal delivered it material upfront proceeds of US$40 million to US$43 million, with a potential earn-out of up to US$32 million in 2030.

An additional consideration would be determined by Invictus' future business growth, Navigator added.

The company said the transaction implied a materially higher valuation for Invictus compared to its initial investment in 2022.

Navigator added:

For NGI, the Transaction represents a partial realisation at an attractive valuation, while retaining meaningful exposure to Invictus' ongoing growth and performance over the multi-year period to 2030 through retained interests, existing carried interest and fund investments, and potential future consideration. The Initial Closing is expected to occur in the first quarter of 2027, subject to customary closing conditions and regulatory approvals. It is anticipated to deliver a significant return on NGI's invested capital, with value realised through upfront proceeds at the Initial Closing, potential earn-out consideration and additional consideration at the Deferred Closing in 2031.

Navigator Chief Investment Officer Ross Zachary said the deal "serves as an example of how NGI's partnership model can create value for all stakeholders of alternative investment management firms''.

Navigator added:

NGI first partnered with Invictus in August 2022, with total consideration of approximately US$115 million paid over three years. Since then, Invictus has more than tripled gross assets, generating strong outcomes for its investors and extending its leadership position in the U.S. residential mortgage credit market. The results of the partnership, including distributions received by NGI and the growth in the value of NGI's interests before consideration of the Transaction, have exceeded NGI's return targets and generated an attractive return for shareholders.

Analysts like the look of the deal

Barrenjoey analysts said in a note to clients that the deal highlights that the price for one of Navigator's private market firms was well above the valuation it is trading on.

They added:

We estimate a PE for the sale in the high teens, perhaps into the 20s based on management fee-only profits.

Barrenjoey has a price target of $4.20 for Navigator shares, compared with the current $2.43.

Macquarie also issued a new research note on Navigator following the announcement, with a price target of $3.24.

Navigator is valued at $1.51 billion.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Sell written several times on board.
Broker Notes

Sell alert! Expert calls time on Corporate Travel and CBA shares

A leading expert expects CBA and Corporate Travel shares to face significant headwinds.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Expert names Woodside and CSL shares as top buys today

A leading expert says now is the time to buy CSL and Woodside shares. But why?

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares

Here's what Mark Gardner from MPC Markets thinks of these three ASX shares.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Broker Notes

Buy, hold, sell: Premier Investments, New Hope, Xero shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

Up 120%, is it too late to buy Codan shares?

Bell Potter thinks this high-flying stock could keep rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could nearly triple in value Bell Potter says

A big development in the US is good news for this company.

Read more »

two cute young boys dressed in business suits sit amid a pile of papers with a calculator and adding machine looking very happy for themselves.
Broker Notes

Buy, hold, sell: Fortescue, Westpac, CSL shares

One of these ASX shares is forecast to climb another 9% over the next 12 months.

Read more »

Woman working on her laptop at a café.
Broker Notes

Buy, hold, sell: Woodside, Life360, Ramsay Health Care shares

New stock tips for investors this week.

Read more »